Both ALGS and CHH are diseases characterized by a variable expression and penetrance, consistent with the distinct phenotype documented in the relatives of the probands, which suggests that mechanisms, yet to be identified, are likely to contribute to the clinical expression of JAG1 gene defects. This evidence concerns the gene JAG1 and cartilage-hair hypoplasia.